Flebogamma 5% DIF ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
65原発性免疫不全症候群1

65. 原発性免疫不全症候群


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00634569
(ClinicalTrials.gov)
May 20085/3/2008Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric SubjectsEvaluation of the Efficacy and Safety of Flebogamma 5% DIF [Immune Globulin Intravenous (Human)] for Replacement Therapy in Pediatric Subjects With Primary Immunodeficiency Diseases.Primary Immune Deficiency DiseaseBiological: Flebogamma 5% DIFInstituto Grifols, S.A.NULLCompleted2 Years16 YearsAll24Phase 4United States